Ovarian Cancer Trial, Recruiting NCT06727487 Sponsor: Universidad Pontificia Comillas Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT06727487
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman who has reached the legal adult age in your country and are no older than 45 years old.
  • You were still having regular periods before starting chemotherapy (if you received chemotherapy).
  • You have been diagnosed with breast cancer confirmed by a tissue sample, your cancer responds to hormones (estrogen and/or progesterone), and your cancer is at an early to intermediate stage (Stage I to III).
  • You have already completed any surgery and/or radiotherapy needed to treat the cancer in the breast or nearby area.
  • You are currently taking medication to suppress your ovaries (a type of hormone treatment), and this treatment is expected to continue for at least 4 months from the start of the study.
  • You are generally able to carry out everyday activities with little to no limitation (as assessed by a standard medical activity scale).
  • You are able to understand the study information and are willing to sign a written consent form.

Who may not be able to join:

  • You have a medical condition that means it would not be safe for you to do physical exercise.
  • You have certain heart or lung warning signs that would make it unsafe to do a fitness/cardiovascular test (confirm with trial site).
  • Your cancer has spread to other parts of the body, or you have another active cancer.
  • You are currently pregnant or breastfeeding.
  • You have a current problem with alcohol or drug misuse (note: smoking is not included in this restriction).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Julio C de la Torre, Ph.D, Universidad Pontificia Comillas

Phone: +34678581021

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universidad Pontificia Comillas
Registry
ClinicalTrials.gov
Start date
15 November 2024
Est. completion
15 April 2025

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Combined intervention evaluation on weight control; Combined intervention evaluation in body composition

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov